-U.S. FDA has reviewed the Investigational New Drug (IND) amendment for the Phase 3 clinical studies...

-Both companies sign an expanded agreement to develop next-generation pneumococcal vaccines.-SK bios...

-SK bioscience’s first mRNA vaccine candidate is expected to enter clinical trials in Australia in F...

This approval paves the way for exports to the world´s fourth most populous country.SK bioscience ai...

SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conj...

SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of ...

-The Coalition for Epidemic Preparedness Innovations (CEPI) visited Korea to discuss collaboration w...

-The company invests USD 2 million in Sunflower, a U.S. biotech company with unique protein manufact...

-The company signs a direct power purchase agreement with SK E&S for 23,000 megawatts of renewab...

-The company secures management control of IDT Biologika, a global CDMO company with state-of-the-ar...

-Company exported 440,000 doses to Thailand, marking its entry into the Southeast Asian market and t...

-Prof. Holmgren recognized for developing the world’s first effective oral cholera vaccine.-Profs. G...